Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04465487
Title Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Angeles Clinic and Research Institute - Clinic/Outpatient Facility Los Angeles California 90025 United States Details
H.Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
START South Texas Accelerated Research Therapeutics Grand Rapids Michigan 49503 United States Details
Hospital Universitario Vall d'Hebrón Barcelona 08035 Spain Details
ICO l'Hospitalet - Hospital Duran i Reynals Barcelona 08908 Spain Details
MD Anderson Cancer Center Madrid 28033 Spain Details
Hospital Universitario Ramon y Cajal Madrid 28034 Spain Details
Hospital Universitario Fundacion Jimenez Madrid 28040 Spain Details
Hospital Universitario HM Sanchinarro Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field